Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
MedifastFRA:MDF -0.30%61 Cash-to-Debt is 6.15 as of Jun. 2026, which is 38% below its 10-year median of 9.86. GuruFocus rates FRA:MDF with a GF Score™ of 61/100 and a GF Value™ of €7.16 (Significantly Overvalued). The stock has 4 warning signs investors should review. Among 94 Personal Services companies, Medifast ranks better than 88.3% on this metric.
Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Medifast's cash to debt ratio for the quarter that ended in Jun. 2026 was 6.15.
If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. Here we can see, Medifastcould pay off its debt using the cash in hand for the quarter that ended in Jun. 2026.
The historical rank and industry rank for Medifast's Cash-to-Debt or its related term are showing as below:
FRA:MDF'
s Cash-to-Debt Range Over the Past 10 Years
Min: 1.09 Med: 9.86 Max: No Debt
Current: 6.15
During the past 13 years, Medifast's highest Cash to Debt Ratio was No Debt. The lowest was 1.09. And the median was 9.86.
FRA:MDF's Cash-to-Debt is ranked better than 88.3% of 94
companies
in the Personal Services industry
Industry Median: 0.64
vs FRA:MDF: 6.15
If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.
Medifast Cash-to-Debt Related Terms
Medifast Cash-to-Debt Historical Data
* Premium members only.
The historical data trend for Medifast's Cash-to-Debt can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
FRA:MDF vs RGS, CLIK, DROR: Cash-to-Debt Comparison
For the Personal Services subindustry, Medifast's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medifast Cash-to-Debt vs Personal Services Industry
For the Personal Services industry and Consumer Cyclical sector, Medifast's Cash-to-Debt distribution charts can be found below:
* The bar in red indicates where Medifast's Cash-to-Debt falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medifast (FRA:MDF) has a Cash-to-Debt of 6.15 as of Jun. 2026. This is 38% below median its historical median of 9.86. Over the past decade, Medifast's Cash-to-Debt has ranged from 1.09 to 10,000.00. According to the industry distribution chart, Medifast ranks #11 out of 94 companies in the Personal Services industry, placing it in the top 11.7%.
Is Medifast's Cash-to-Debt too high?
Medifast's current Cash-to-Debt of 6.15 is 38% below median its 10-year median of 9.86. Over the past 10 years, this metric has ranged from a low of 1.09 to a high of 10,000.00. The Personal Services industry median Cash-to-Debt is 0.64. Medifast's value of 6.15 is 860.9% above this industry median. Based on the distribution chart, Medifast ranks #11 out of 94 companies in the Personal Services industry, which is in the top quartile — a strong position relative to peers. Overall, Medifast has a GF Score™ of 61/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Medifast's Cash-to-Debt compare to RGS and CLIK?
According to the Personal Services industry distribution chart, Medifast ranks #11 out of 94 companies for Cash-to-Debt. This places Medifast in the top 12% of its industry — outperforming the majority of peers. The industry median Cash-to-Debt is 0.64. Medifast's value of 6.15 is 860.9% above this benchmark. Historically, Medifast's own Cash-to-Debt has ranged from 1.09 to 10,000.00 over the past decade. While the company's 10-year median is 9.86 vs. the industry median of 0.64, Medifast has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash-to-Debt for a Personal Services company?
The median Cash-to-Debt among Personal Services companies is 0.64, based on 94 companies in the industry. Companies in the top quartile (top 25%) have a Cash-to-Debt significantly above this median, while those in the bottom quartile fall well below. However, Cash-to-Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medifast's current Cash-to-Debt of 6.15 is 860.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash-to-Debt mean?
A high Cash-to-Debt can signal that a stock is expensive relative to its fundamentals. For the Personal Services industry, the median Cash-to-Debt is 0.64 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medifast's current Cash-to-Debt is 6.15, which is 38% below median its own 10-year median of 9.86. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medifast stock overvalued right now?
Based on GuruFocus' analysis, Medifast (FRA:MDF) is currently considered Significantly Overvalued. The stock's GF Value™ is €7.16, compared to a current price of €9.90 — trading 38.3% above its estimated fair value. The current Cash-to-Debt is 6.15, which is 38% below median its 10-year median of 9.86 and 860.9% above the Personal Services industry median of 0.64. Medifast's overall GF Score™ is 61/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash-to-Debt calculated?
Cash-to-Debt is calculated from a company's financial statements. For Medifast (FRA:MDF), the current Cash-to-Debt is 6.15 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medifast (FRA:MDF) Overvalued in 2026?
Based on GuruFocus' analysis, Medifast stock appears to be overvalued.
The current stock price of €9.90 is trading 38.3% above its estimated GF Value™ of €7.16.
GuruFocus considers Medifast to be Significantly Overvalued.
Key valuation signals for FRA:MDF:
Cash-to-Debt: 6.15 (38% below median its 10-year median of 9.86)
GF Value™: €7.16 vs. price of €9.90 (38.3% above fair value)
Industry Position: 860.9% above the Personal Services median (#11 of 94)
No single metric tells the full story. See the FRA:MDF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medifast Inc is a old health and wellness company known for its habit-based and coach-guided lifestyle solution OPTAVIA, which provides people with a simple, yet comprehensive approach to address obesity and support a healthy life. The company provides unparalleled coaching support along with community, tailored nutrition and healthy habits, and empowers people to master their weight loss journey through each stage of life. The company has access to GLP-1 medications where clinically appropriate. The company is focused on offering talent to Lifelong Transformation, Making a Healthy Lifestyle Second Nature.
61GF Score
Get the complete analysis for FRA:MDF
Cash-to-Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:MDF has been successfully added to your 
